Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Specimen Handling 3Cisplatin 3Magnetic Resonance Spectroscopy 2Letrozole 2Human Papillomavirus Recombinant Vaccine nonavalent 2Diosmin 2Carboplatin 2trametinib 1toripalimab 1tocilizumab 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1rozanolixizumab 1pyrotinib 1pirtobrutinib 1olutasidenib 1obinutuzumab 1niraparib 1naldemedine 1idelalisib 1human papillomavirus vaccine, L1 type 16, 18 1fluciclovine F-18 1enfortumab vedotin 1darolutamide 1dabrafenib 1cabozantinib 1apalutamide 1adacel 1acalabrutinib 1Watchful Waiting 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Metronidazole × 30 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡